GlaxoSmithKline PLC (GSK)

GSK (NYSE:Drugs) EQUITY
$41.23
pos +0.02
+0.05%
Today's Range: 40.56 - 41.25 | GSK Avg Daily Volume: 4,110,200
Last Update: 08/28/15 - 3:16 PM EDT
Volume: 2,181,073
YTD Performance: -3.58%
Open: $40.57
Previous Close: $41.21
52 Week Range: $39.27 - $49.24
Oustanding Shares: 2,171,250,000
Market Cap: 87,870,487,500
6-Month Chart
TheStreet Ratings Grade for GSK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 5 5 5 5
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 2.63 2.63 2.63 2.63
Latest Dividend: 0.59
Latest Dividend Yield: 6.12%
Dividend Ex-Date: 08/12/15
Price Earnings Ratio: 13.91
Price Earnings Comparisons:
GSK Sector Avg. S&P 500
13.91 6.80 24.79
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-7.62% -15.33% -11.36%
GROWTH 12 Mo 3 Yr CAGR
Revenue -18.10 -0.16 -0.06
Net Income -52.50 -0.48 -0.19
EPS -51.60 -0.45 -0.18
Earnings for GSK:
EBITDA 8.52B
Revenue 35.81B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $0.64 $0.70 $2.39 $2.66
Number of Analysts 1 1 6 6
High Estimate $0.64 $0.70 $2.50 $2.78
Low Estimate $0.64 $0.70 $2.30 $2.54
Prior Year $0.90 $0.82 $2.84 $2.39
Growth Rate (Year over Year) -28.89% -14.63% -15.73% 11.14%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Not many, according to filings from Tweedy Browne and Kahn Brothers.
They should learn to trust techs, financials.
As health-care stocks rally, it's time for politicians to move on.
Have it ready in case market turns volatile.
Deals coming fast and furious in the best group in town.
Combined Heinz-Kraft heads a long second-quarter list.
Approval of malaria vaccine could provide a shot in the arm.

Merger Mania Benefits Mylan Real Money Pro($)

Whether it's acquiring or the acquired, Mylan is building shareholder value.
Americans are living much longer these days -- and there are a number of ways to invest.
Stop picking on PepsiCo, Allergan and Apple.

Columnist Conversations

The DBC is surging again today. Yesterday the commodity index jumped 3.6% closing above an overhead trend...
What is the purpose of Fed Transparency if it isn't too add some level of certainty? As Time Magazine wrote "...
Wish you had brought some cooler weather with you, we're in a sauna here.
Out on the West Coast -- not in on Monday. So Monday's "Trade of the Week" coming up today in my Diary now. Sh...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.